Hagit Eliyahu
Hebrew University of Jerusalem
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hagit Eliyahu.
CSH Protocols | 2011
Ira Yudovin-Farber; Hagit Eliyahu; Abraham J. Domb
Polycations are effective nonviral carriers for gene delivery systems. These carriers vary in molecular weight, polymer structure, polymer:DNA ratio, molecular architecture, and the ability to introduce target-specific moieties. Polycations are capable of complexing various plasmids and transfecting them into different cells to produce a high yield of a desired protein. Cationic polysaccharides are attractive candidates for gene delivery. They are natural or semi-natural, nontoxic, biodegradable, and biocompatible materials that can be modified for improved physicochemical properties. Cationic polysaccharides are synthesized by conjugation of various oligoamines to oxidized polysaccharides via reductive amination. These conjugates have been rigorously tested for gene delivery in cultured cells and in animals. From more than 300 polysaccharide-oligoamine derivatives tested, only dextran-spermine (D-SPM) was found to be highly effective in gene transfection, both in vitro and in vivo. This protocol describes the synthesis of cationic polysaccharides and their use for DNA transfection in vitro.
Archive | 2003
Dmitri Simberg; Danielle Hirsch-Lerner; Nicolaas-Jan Zuidam; Simcha Even-Chen; Miryam Kerner; Hagit Eliyahu; Natalie Servel; Sarah Weisman; Alla Plis-Finarov; Yeshayahu Talmon; Yechezkel Barenholz
Lipoplexes are complexes formed spontaneously upon mixing of negatively charged nucleic acids (or other polyelectrolytes such as proteins) with positively-charged lipid assemblies [1]( for definitions see [2]). The relevant nucleic acids include plasmid DNA (pDNA), linear DNA, single chain DNA, oligonucleotide (ODN), messenger RNA, and silencing double stranded short RNA (siRNA) [1, 2, 3] The lipoplex-mediated nucleic acid delivery appears to be a promising system for a broad spectrum of both in vitro and in vivo applications in life sciences, biotechnology, medicine, and agriculture [1]. These applications are referred to as “lipofection”, namely, lipoplex- mediated transfection [2]. Among all currently available nonviral delivery systems, lipoplexes are one of the most popular and most versatile. This “popularity” is explained by the following:
Molecules | 2005
Hagit Eliyahu; Yechezkel Barenholz; A. J. Domb
Journal of Medicinal Chemistry | 2002
Tony Azzam; Hagit Eliyahu; Libi Shapira; Michal Linial; Yechezkel Barenholz; Abraham J. Domb
Biochimica et Biophysica Acta | 2005
Danielle Hirsch-Lerner; Ming Zhang; Hagit Eliyahu; Marylin E. Ferrari; Carl J. Wheeler; Yechezkel Barenholz
Vaccine | 2006
Aviva Joseph; Noga Itskovitz-Cooper; Sarit Samira; Orli Flasterstein; Hagit Eliyahu; Dmitri Simberg; Itzik Goldwaser; Yechezkel Barenholz; Eli Kedar
Journal of Controlled Release | 2004
Tony Azzam; Hagit Eliyahu; Arik Makovitzki; Michal Linial; Abraham J. Domb
Biomaterials | 2007
Hagit Eliyahu; Aviva Joseph; J.P. Schillemans; Tony Azzam; Avraham Domb; Yechezkel Barenholz
Biomaterials | 2006
Hagit Eliyahu; Shahar Siani; Tony Azzam; Abraham J. Domb; Yechezkel Barenholz
Biomaterials | 2006
Hagit Eliyahu; Aviva Joseph; Tony Azzam; Yechezkel Barenholz; Abraham J. Domb